For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260501:nRSA6905Ca&default-theme=true
RNS Number : 6905C Helios Underwriting Plc 01 May 2026
1 May 2026
Helios Underwriting plc
('Helios' or 'the Company')
Total Voting Rights
Helios, the only publicly traded company offering instant access to a diverse
portfolio of syndicates at Lloyd's of London, the world's largest insurance
market, announces that as at 30 April 2026, the Company's issued share capital
consisted of 75,216,173 ordinary shares of £0.10 each ("Ordinary Shares").
The Company holds 5,707,941 Ordinary Shares in treasury. The total number of
voting rights in the Company is therefore 69,508,232. This figure may be used
by shareholders as the denominator for the calculations by which they will
determine if they are required to notify their interest in, or a change to
their interest in, the Company under the FCA's Disclosure Guidance and
Transparency Rules.
For further information, please contact:
Helios Underwriting plc
Louis Tucker - Chief Executive Officer
+44 (0)20 3965
6441
Adhiraj Maitra - Director of Finance and Operations +44 (0)20
3743 2114
Peel Hunt (Nomad, Broker and Financial Adviser)
Dan Webster / Andrew Buchanan / Martin Frowde +44 (0) 20
7418 8900
FTI Consulting
Ed
Berry
+44 (0)7703 330 199
Christian Harte
+44 (0)7974 288 763
About Helios
Helios provides a limited liability direct investment into the Lloyd's
insurance market and is quoted on the London Stock Exchange's AIM market
(ticker: HUW). Helios trades within the Lloyd's insurance market. The
portfolio provides a broad spread of business primarily participating in the
US and other international wholesale and reinsurance markets. For further
information please visit www.huwplc.com (http://www.huwplc.com) .
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END TVRWPUUUCUPQGBU
Copyright 2019 Regulatory News Service, all rights reserved